SLC5A11 and myeloid sarcoma: Of note, the OL-SLC5A11 subtype was characterized by a specific expression of ACSBG1 and LINGO1, the latter one encoding a protein known to inhibit OPC differentiation and therefore might inhibit remyelination in MS lesions [39] (Fig. 4h, Suppl.